Current trends in the treatment of uraemia: a view from the United States.
作者信息
Bakir A A, Dunea G
出版信息
Br Med J. 1979 Apr 7;1(6168):914-6. doi: 10.1136/bmj.1.6168.914.
Abstract
摘要
相似文献
1
Current trends in the treatment of uraemia: a view from the United States.尿毒症治疗的当前趋势：来自美国的视角。
Br Med J. 1979 Apr 7;1(6168):914-6. doi: 10.1136/bmj.1.6168.914.
2
[Cardio-pulmonary radiological aspects in chronic uremia and renal transplantation].[慢性尿毒症及肾移植中的心肺放射学方面]
Arch Monaldi. 1981 Jan-Apr;36(1-2):3-22.
3
The dialysis branch of a transplantation unit.移植单位的透析科
Scand J Urol Nephrol. 1973;7(1):50-5. doi: 10.3109/00365597309133672.
4
The management of dialysis and transplantation in children.儿童透析与移植的管理
J Dial. 1976;1(1):75-102. doi: 10.3109/08860227609039139.
5
[How to palliate kidney destruction in children].[如何缓解儿童肾脏破坏]
Nouv Presse Med. 1974 Dec 21;3(44):2648-50.
6
Hemodialysis and transplantation in adults with polycystic renal disease.成人多囊肾病的血液透析与移植
JAMA. 1971 Sep 27;217(13):1821-4.
7
Impact of HR-1 on the therapy of end-stage uremia. How and where should uremia be treated.
N Engl J Med. 1973 Jun 14;288(24):1286-8. doi: 10.1056/NEJM197306142882408.
8
Results of 12 years' treatment of chronic renal failure by dialysis and transplantation.透析和移植治疗慢性肾衰竭12年的结果。
Can Med Assoc J. 1978 Feb 4;118(3):263-6.
9
Dialysis therapy and transplantation in uremia: which to use when.尿毒症的透析治疗与移植：何时选用何种治疗方法。
Postgrad Med. 1978 Nov;64(5):169-79. doi: 10.1080/00325481.1978.11714979.
10
Dialysis in chronic renal failure.慢性肾衰竭的透析治疗
Prog Biochem Pharmacol. 1974;9:221-38.
本文引用的文献
1
Comparison of "PTFE" and bovine grafts for blood access in dialysis patients.透析患者血液通路中“聚四氟乙烯”移植物与牛移植物的比较。
Trans Am Soc Artif Intern Organs. 1976;22:388-93.
2
Expanded polytetrafluoroethylene (PTFE) subcutaneous arteriovenous conduit: an improved vascular access for chronic hemodialysis.
Trans Am Soc Artif Intern Organs. 1976;22:382-7.
3
Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors.使用抗淋巴细胞球蛋白进行尸体供肾移植的七年经验。
Ann Surg. 1976 Sep;184(3):352-68. doi: 10.1097/00000658-197609000-00013.
4
Outcome of treatment for end-stage renal disease.终末期肾病的治疗结果。
Arch Intern Med. 1978 Oct;138(10):1469-70.
5
Critical comparison of renal transplant survival between recipients of live related donor and cadaver organs.活体亲属供肾与尸体供肾受者肾移植存活率的批判性比较。
Surg Gynecol Obstet. 1978 Apr;146(4):519-23.
6
Predicting treatment costs and life expectancy for end-stage renal disease.预测终末期肾病的治疗成本和预期寿命。
N Engl J Med. 1978 Feb 16;298(7):372-8. doi: 10.1056/NEJM197802162980705.
7
Pragmatic realities in uremia therapy.
N Engl J Med. 1978 Feb 16;298(7):368-71. doi: 10.1056/NEJM197802162980704.
8
Immunologic factors determining survival of cadaver-kidney transplants. The effect of HLA serotyping, cytotoxic antibodies and blood transfusions on graft survival.决定尸体肾移植存活的免疫因素。HLA血清分型、细胞毒性抗体及输血对移植物存活的影响。
N Engl J Med. 1978 Oct 12;299(15):793-8. doi: 10.1056/NEJM197810122991502.
9
Factors contributing to the declining mortality rate in renal transplantation.
N Engl J Med. 1978 Dec 14;299(24):1321-5. doi: 10.1056/NEJM197812142992401.
10
Antithymocyte globulin in renal transplant recipients. Report of a prospective randomized controlled trial.肾移植受者中的抗胸腺细胞球蛋白。一项前瞻性随机对照试验的报告。
Arch Surg. 1976 Jun;111(6):680-3. doi: 10.1001/archsurg.1976.01360240060010.
Zotero 插件